Psychedelic Drug Legislative Reform and Legalization in the US
JAMA Psychiatry December 7, 2022 Joshua S. Siegel, James E. Daily, Demetrius A. Perry et al. 168 citations
Between 2019 and 2022, 25 U.S. states considered 74 bills related to psychedelic drugs, with 10 enacted and 32 still active. The number of bills introduced each year rose from 5 in 2019 to 36 in 2022. Most bills (90%) specified psilocybin, and 58% proposed decriminalization, though few included medical oversight or licensure requirements. Early legislative efforts occurred in liberal states, but the partisan gap has narrowed, suggesting reform is becoming bipartisan. An analytic model based on marijuana legalization projects that a majority of states will legalize psychedelics by 2034 to 2037.